Columbia Partners L L C Investment Management Lowers stake in IMAX Corporation (USA) (IMAX)

IMAX Corporation (USA) (IMAX) : Columbia Partners L L C Investment Management reduced its stake in IMAX Corporation (USA) by 4.13% during the most recent quarter end. The investment management company now holds a total of 503,217 shares of IMAX Corporation (USA) which is valued at $16,183,459 after selling 21,671 shares in IMAX Corporation (USA) , the firm said in a disclosure report filed with the SEC on May 10, 2016.IMAX Corporation (USA) makes up approximately 1.17% of Columbia Partners L L C Investment Management’s portfolio.

Other Hedge Funds, Including , Gerber Kawasaki Wealth Investment Management boosted its stake in IMAX in the latest quarter, The investment management firm added 12,462 additional shares and now holds a total of 194,127 shares of IMAX Corporation (USA) which is valued at $6,384,837. IMAX Corporation (USA) makes up approx 4.45% of Gerber Kawasaki Wealth Investment Management’s portfolio.Rice Hall James Associates reduced its stake in IMAX by selling 1,962 shares or 0.23% in the most recent quarter. The Hedge Fund company now holds 841,597 shares of IMAX which is valued at $26,931,104. IMAX Corporation (USA) makes up approx 1.58% of Rice Hall James Associates’s portfolio.Huntington National Bank boosted its stake in IMAX in the latest quarter, The investment management firm added 835 additional shares and now holds a total of 2,620 shares of IMAX Corporation (USA) which is valued at $83,840. Jfs Wealth Advisors sold out all of its stake in IMAX during the most recent quarter. The investment firm sold 1,060 shares of IMAX which is valued $33,920.

IMAX Corporation (USA) opened for trading at $32.18 and hit $32.75 on the upside on Monday, eventually ending the session at $32.42, with a gain of 0.81% or 0.26 points. The heightened volatility saw the trading volume jump to 4,16,499 shares. Company has a market cap of $2,214 M.

On the company’s financial health, IMAX Corporation (USA) reported $0.22 EPS for the quarter, beating the analyst consensus estimate by $ 0.06 according to the earnings call on Apr 21, 2016. Analyst had a consensus of $0.16. The company had revenue of $92.10 million for the quarter, compared to analysts expectations of $83.91 million. The company’s revenue was up 48.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.07 EPS.

Many Wall Street Analysts have commented on IMAX Corporation (USA). Company shares were Reiterated by MKM Partners on Apr 22, 2016 to “Buy”, Firm has raised the Price Target to $ 40 from a previous price target of $39 .Wedbush Upgraded IMAX Corporation (USA) on Feb 22, 2016 to ” Outperform”, Price Target of the shares are set at $38.Shares were Reiterated by MKM Partners on Feb 22, 2016 to “Buy” and Lowered the Price Target to $ 39 from a previous price target of $44 .

IMAX Corporation is an entertainment technology company. The Company along with its wholly owned subsidiaries is specialized motion picture technologies and presentations. The Company operates through seven segments: the IMAX systems the theater system maintenance the joint revenue sharing arrangements film production and IMAX DMR film distribution film post-production and other. The Company’s businesses include the design and manufacture of theater systems (IMAX theater systems) and the sale lease or contribution of those systems to customers and the digital re-mastering of films into the IMAX format and the exhibition of those films in the IMAX theater network. Its trademarks include IMAX IMAX Dome IMAX 3D IMAX 3D Dome Experience It In IMAX The IMAX Experience and An IMAX Experience among others. The Company owns approximately 934 theater systems (828 commercial and 106 institutional) operating in 62 countries.

Leave a Reply

IMAX Corporation (USA) - Is it time to Sell?

Top Brokerage Firms are advising their investors on IMAX Corporation (USA). Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.